Method For Controlling Gallium Content in Gadolinium-Gallium Garnet Scintillators
AssigneeSiemens Medical Solutions USA, Inc.
InventorsPeter Carl Cohen, Alexander Andrew Carey, Mark S. Andreaco
Life of this patent
Estimating the term…
Loading patent…
AssigneeSiemens Medical Solutions USA, Inc.
InventorsPeter Carl Cohen, Alexander Andrew Carey, Mark S. Andreaco
Estimating the term…
Disclosed herein is a method including manufacturing a powder having a composition of formula (1), M1aM2bM3cM4dO12 (1) where O represents oxygen, M1, M2, M3, and M4 represents a first, second, third, and fourth metal that are different from each other, where the sum of a+b+c+d is about 8, where “a” has a value of about 2 to about 3.5, “b” has a value of 0 to about 5, “c” has a value of 0 to about 5 “d” has a value of 0 to about 1, where “b” and “c”, “b” and “d”, or “c” and “d” cannot both be equal to zero simultaneously, where M1 is a rare earth element comprising gadolinium, yttrium, lutetium, scandium, or a combination of thereof, M2 is aluminum or boron, M3 is gallium, and M4 is a dopant; and heating the powder to a temperature of 500 to 1700° C. in an oxygen containing atmosphere to manufacture a crystalline scintillator.
A method comprising:
An article manufactured by a method comprising:
Dependencies are inferred from the claim text.